Saturday, August 05, 2017 10:09:58 PM
ASX:CDY
Cellmid (ASX:CDY)
Serious IP in Cancer Diagnostics & Treatment
Micocap de-risked by multiple diverse income steams.
Very Solid Revenue growth (Trading a low revenue multiple <10)
New sales channels just opened up for it's hair care range & expecting USA & China revenues to be booked this month (Aug 2017) - forecasting cashflow positive catalyst
This week the chart is lifting of it's 5year historical base
Company has forecast sales of 100mln (current market cap it 30mln)
Anyone have a view?
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
